Despite advances in the understanding of the metabolic causes of<unk> , treatments aimed at interrupting these pathological processes have been limited by side effects and lack of efficacy. Thus, with the exception of tight glucose control, treatments are for reducing pain and other symptoms and do not address the underlying problems.
Agents for pain control include tricyclic antidepressants (TCAs), serotonin reuptake inhibitors (Selective serotonin reuptake inhibitor/ SSRIs) and antiepileptic drugs (AEDs). A systematic review concluded that "tricyclic antidepressants and traditional anticonvulsants are better for short term pain relief than newer generation anticonvulsants."
Diabetic neuropathy medical therapy
Peripheral neuropathy medical therapy
Diabetic nephropathy medical therapy
Diabetic retinopathy medical therapy
Peripheral arterial disease medical therapy
Otosclerosis medical therapy
Bartter syndrome medical therapy
Peripheral neuropathy interventions